The epithelial-mesenchymal transition (EMT) is crucial for the invasion and metastasis of many epithelial tumors including colorectal carcinoma (CRC). In the present study, a scattering and fibroblastic morphology with reduced intercellular contacts was found in the SW480 colon cancer cells overexpressing the gene encoding thymosin b4 (Tb 4 ), which was accompanied by a loss of E-cadherin as well as a cytosolic accumulation of b-catenin, two most prominent markers of EMT. Whereas E-cadherin downregulation was likely to be accounted by a ZEB1-mediated transcriptional repression, the accumulation of b-catenin was a result of glycogen synthase kinase-3b inactivation mediated by integrin-linked kinase (ILK) and/or its downstream effector, Akt. Intriguingly, ILK upregulation in Tb 4 -overexpressing SW480 cells seemed to be attributed mainly to a stabilization of this kinase by complexing with particularly interesting new Cys-His protein (PINCH) more efficiently. In the meantime, a strong correlation between the expression levels of Tb 4 , ILK and E-cadherin in CRC patients was also revealed by immunohistochemical analysis. Taken together, these data suggest a novel role of Tb 4 in promoting CRC progression by inducing an EMT in tumor cells via upregulating ILK and consequentially its signal transduction.
Introduction
Epithelial-mesenchymal transition (EMT), a process by which cells lose their polarized epithelial structures and concomitantly acquire a migratory or mesenchymal phenotype (Savagner, 2001; Thiery, 2002; Vernon and LaBonne, 2004) , is essential for normal embryonic development and for progression of non-invasive adenomas into malignant, metastatic carcinomas. Alterations in cell-cell adhesion, cell-substrate interaction, extracellular matrix degradation and cytoskeleton organization are the major events occurred during EMT (Savagner, 2001; Thiery, 2002) , which is also highlighted by the loss of E-cadherin, a type I transmembrane protein of the adherens junction (Kang and Massague, 2004 ). E-cadherin mediates calcium-dependent homophilic interactions by its extracellular domain, whereas anchoring the adhesion complex to the actin cytoskeleton by binding with catenins through its intracellular domain (Kemler, 1992; Takeichi, 1995) . Because it not only stabilizes cell adhesion but also inhibits cell migration, E-cadherin has been shown to be a potent inhibitor of tumor invasion both in vitro (Behrens et al., 1989; Frixen et al., 1991; Vleminckx et al., 1991) and in vivo (Meiners et al., 1998; Perl et al., 1998) .
Molecular mechanisms underlying E-cadherin downregulation have been unraveled in recent years. For example, surface E-cadherin molecule has been shown cleaved by both stremolysin-1 (Lochter et al., 1997) and matrilysin (matrix metalloproteinases (MMP)-7) (Zucker et al., 2000) to release a soluble E-cadherin (sE-CAD), which could inhibit the functions of its parental molecule in a paracrine manner. Cleavage of the intracellular domain of E-cadherin by caspase-3 and presinilin-1/g-secretase has been reported in MDCK (Madin-Darby canine kidney) (Keller and Nigam, 2003) and A431 cells (Marambaud et al., 2002) , respectively. Moreover, ubiquitination and endocytosis of E-cadherin/ catenin complex has been shown to be promoted by Hakai, an E-cadherin binding protein with E3-ubiquitin ligase activity (Fujita et al., 2002) , and the internalized E-cadherin is then shuttled to lysosome for degradation (Palacios et al., 2005) . In the meantime, downregulation of E-cadherin has also been attributed to a variety of gene silencing events such as mutations in its gene (Pecina-Slaus et al., 2005) , hypermethylation of its promoter (Yoshiura et al., 1995; Tamura et al., 2000) or a combination of mutations in one allele with loss or inactivation of another (Risinger et al., 1994) . In addition, transcription of E-cadherin has been reported to be suppressed by factors such as Snail (Batlle et al., 2000; Cano et al., 2000) , Slug (Hajra et al., 2002; Bolo´s et al., 2003) , ZEB1/dEF1 (Guaita et al., 2002) , ZEB2/ SIP-1 (Comijn et al., 2001) and E12/E47 factor (Pe´rez-Moreno et al., 2001) in different types of cancers. More recently, E-cadherin expression has been shown to be suppressed by integrin-linked kinase (ILK), a serine/ threonine protein kinase that interacts with the cytoplasmic domain of b-integrins and growth factor receptors (Wu et al., 1998) . Besides inducing EMT, ILK has been implicated in the regulation of anchorageindependent cell growth and survival, cell-cycle progression, invasion and migration, cell motility and contraction, vascular development and tumor angiogenesis (Hannigan et al., 2005) . Concordantly, increased ILK expression and activity were found in prostate, colon, gastric and ovarian cancers, as well as in malignant melanomas (Hannigan et al., 2005) .
Our previous study has shown that overexpression of thymosin b4 (Tb 4 ), a gene encoding the major G-actin sequestering peptide (Sanders et al., 1992) in the SW480 colon carcinoma cells causes a dramatic decrease in both the total and intercellular levels of E-cadherin, which was postulated to result from a disruption of the adherens junction owing to the depolymerization of actin microfilaments triggered by this peptide (Wang et al., 2003) . These Tb 4 overexpressers, in addition, also exhibited anchorage-independent as well as highly migratory and invasive phenotypes (Wang et al., 2003 (Wang et al., , 2004 . However, the precise mechanism(s) for Tb 4 -induced EMT-like phenotypic changes in the aforementioned colon cancer cells has not been elucidated. To address these questions, several new Tb 4 -overexpressing SW480 stable clones with morphology and property highly resembling those of the mesencymal cells were established and the involvement of ILK in triggering EMT in these lines was analysed, as Tb 4 has recently been reported to activate ILK in cardiomyocytes (BockMarquette et al., 2004) .
Results

Tb4 induces EMT in SW480 colon cancer cells
To examine the effects of Tb 4 overexpression on the EMT in colon cancer cells, stable clones were established from SW480 colon carcinoma cells as described previously (Wang et al., 2003) . Transgene expression (mouse Tb 4 mRNA) was clearly detected in two new Tb 4 -overexpressing stable lines, Tb3 and Tb4 (Figure 1a) . Interestingly, these new Tb 4 overexpressers not only exhibited an elongated, fibroblastic morphology but also showed a loose association and occasional misorientation compared to the closely contacted monolayer, cobblestone-like parental (SW) and the vector-transfected (BK) cells (Figure 1b) . To determine whether the above phenotypic changes were accompanied by an alteration in the expression of epithelial marker, E-cadherin, and its associated protein-b-catenin, Western blot analysis was performed. Although much lower levels of E-cadherin were found in Tb3 and Tb4 cells, their b-catenin levels were markedly elevated ( Figure 1c ). E-cadherin downregulation in Tb 4 overexpressers is due to its transcription repression Several possibilities could explain the downregulation of E-cadherin in Tb 4 overexpressers including a cleavage by MMPs, an endocytosis-coupled degradation, or a transcription repression. To examine the involvement of MMPs, we treated SW480, BK, Tb3 and Tb4 cells with or without GM6001, a broad spectrum MMP inhibitor, for 24 h before their E-cadherin levels were analysed. As shown in Figure 2a , levels of this adhesion molecule were not restored by GM6001, suggesting that Ecadherin downregulation in Tb 4 overexpressers is not owing to MMP cleavage. As the endocytosed Ecadherin molecules could be degraded subsequently by either a proteasomal or a lysosomal pathway, we assessed its levels in the aforementioned lines after they were treated with MG132, a proteasome inhibitor, and NH 4 Cl, a lysosomotropic agent, respectively, for 24 h. Surprisingly, both treatments failed to restore the levels of E-cadherin in Tb 4 overexpressers (Figure 2a ), suggesting that neither proteasomal nor lysosomal degradation was responsible for Tb 4 -induced downregulation of this adhesion molecule. Reverse transcriptionpolymerase chain reaction (RT-PCR) analysis was then performed to investigate the participation of transcription repression in downregulating E-cadherin in Tb 4 overexpressers. Indeed, a dramatic reduction in Ecadherin mRNA was found in Tb3 and Tb4 cells (Figure 2b ), implying a decreased transcription of this gene. To delineate its underlying mechanism, expression levels of Snail, Slug and ZEB1, three main transcription repressors for E-cadherin, were determined by RT-PCR. To our surprise, only ZEB1 mRNA levels along with its promoter activity were consistently upregulated in Tb 4 overexpressers (Figure 2b and c) . In the meantime, a Snail-mediated (long-term) E-cadherin repression in Tb3 and Tb4 cells was ruled out because no elevation of Snail mRNA and protein was found (Figure 2b and d) .
Phosphorylations of b-catenin by glycogen synthase kinase-3b and casein kinase 1 are inhibited in Tb 4 overexpressers As total b-catenin levels were increased in Tb 4 overexpressers (Figure 1c) , we examined whether this alteration was due to its transcription activation by RT-PCR analysis. As can be seen in Figure 3a , no apparent increase in b-catenin mRNA could be found in Tb3 and Tb4 cells, excluding the above possibility. The phosphorylation status of b-catenin was then analysed because a reduction of these post-translational modifications could result in its stabilization (Cohen and Frame, 2001; Liu et al., 2002; Polakis, 2002) . Interestingly, diminished phosphorylations at Ser 33 , Ser 37 and Thr 41 (sites for glycogen synthase kinase-3b (GSK-3b)) as well as Ser 45 (site for casein kinase 1 (CK1)) on this anchoring molecule along with increased cytosolic levels were found in Tb3 and Tb4 cells (Figure 3b ), suggesting that GSK-3b activity was greatly decreased, which was further supported by its hyper-phosphorylation ( Figure 3c ).
Increased ILK activity in Tb 4 overexpressers is insensitive to phosphatidylinositol-3 kinase inhibitor To dissect the mechanism for GSK-3b hyper-phosphorylation in Tb3 and Tb4 cells, we examined the expression of ILK, as the levels of this kinase have previously been shown to be stimulated by Tb 4 in cardiomyocytes (Bock-Marquette et al., 2004). Higher
Figure 2 E-cadherin downregulation is associated with ZEB1 upregulation in Tb 4 overexpressers. (a) SW480 (SW) cells and three stable clones derived from them were treated with or without 50 mM galardin (GM6001), 10 mM MG132 or 10 mM NH 4 Cl for 24 h. E-cadherin levels were determined as described in Figure 1 . (b) RT-PCR was performed using total RNAs isolated from various clones derived from SW cells with primers specific for human E-cadherin, Snail, Slug and ZEB1 as described in the 'Materials and methods'. GAPDH levels were analysed for estimating the amount of cDNA in each sample and PCR products was quantified using the Vilber Lourmat analysis software. (c) SEAP reporter assays using the aforementioned four cell lines were performed as described in the 'Materials and methods'. (d) Western blot analysis was carried out with total lysates (50 mg) prepared from SW, BK, Tb3 and Tb4 cells using an anti-Snail antibody as a probe.
ILK levels were indeed detected in both the total lysate (T) and the cytosolic fraction (C) of Tb 4 overexpressers. On the other hand, no change in the levels of a-parvin, an ILK-stimulating protein (Attwell et al., 2003) , was found in these cells (Figure 4a ). Meanwhile, an increased ILK activity in Tb 4 overexpressers suggested by an enhanced phosphorylation (Ser 473 ) of Akt (Figure 4b ), a well-known substrate of ILK, was validated by the in vitro kinase assay ( Figure 4c ). However, the involvement of phosphatidylinositol-3 kinase (PI3K) in activating ILK was ruled out by the failure of treating LY294002, a specific PI3K inhibitor, in suppressing ILK activity of Tb3 and Tb4 cells (Figure 4c ). Concordantly, neither of the RNA levels of E-cadherin could be restored by LY294002 treatment (Figure 4d ), further excluding the role of PI3K as a mediator of ILK signaling in Tb 4 overexpressers.
Increased complex formation with PINCH may be responsible for ILK upregulation in Tb 4 overexpressers To elucidate the mechanism for ILK upregulation in Tb 4 overexpressers, its mRNA levels were first analysed by RT-PCR. As can be seen in Figure 5a , no change in ILK mRNA was detected in Tb3 and Tb4 cells. We next examined the involvement of Akt in stimulating ILK (b) Western blotting of the whole-cell extracts from the aforementioned clones was performed using anti-Akt, anti-p-Akt (Ser 473 ) and anti-b-tubulin antibodies as probes, respectively. (c) SW480, BK, Tb3 and Tb4 cells were treated with or without 25 mM LY294002 for 1 h before being harvested for in vitro kinase assay as described in the 'Materials and methods' using the myelin basic protein (MBP) as a substrate. Protein quantification was performed as described above. (d) E-cadherin mRNA levels in various stable clones before and after LY294002 treatment (50 mM for 24 h) were determined by RT-PCR. translation in these cells because one of its substrates, mammalian target of rapamycin (mTOR), could facilitate translation either by activating the ribosomal p70S6 kinase (S6K1) or by releasing the eucaryotic initiation factor 4E (eIF4E)-binding protein 1 (Penuel and Martin, 1999; Coleman et al., 2004; Yau et al., 2005) . However, no decrease in ILK levels in Tb3 and Tb4 cells was found after being treated with rapamycin, an mTOR inhibitor (data not shown). In the meantime, participation of the mitogen-activated protein kinase pathway in upregulating ILK in Tb 4 overexpressers was also ruled out by the failure of treating PD98059, a MAPK/extracellular signal-regulated kinase (MEK) inhibitor, in suppressing ILK expression (data not shown), even though this signaling has been reported to enhance translation by activating both S6K1 (Sawhney et al., 2004) and eIF4E (Herbert et al., 2002) . On the other hand, no apparent decrease in ILK protein levels was found in Tb4 cells even after they were treated with cycloheximide for 72 h (Figure 5b ). By contrast, most of the parental and the vector-transfected cells were killed by this drug within 24 h (data not shown). Interestingly, higher amount of PINCH was found to be associated with ILK in Tb3 and Tb4 cells (Figure 5c ), suggesting that Tb 4 might promote the complex formation between ILK and PINCH.
Expression of Tb 4 antisense RNA abolishes the upregulation of ILK in Tb 4 overexpressers
Having demonstrated that the expression levels of ILK were increased in Tb 4 overexpressers, we asked whether downregulation of this G-actin binding peptide could alter its expressions. To repress the expression of endogenous Tb 4 , SW480 and BK cells were infected, respectively, with recombinant adenoviruses carrying either the antisense Tb 4 (Ad-Tb 4 AS) or green fluorescent protein (GFP) (Ad-GFP) gene, and the levels of human Tb 4 mRNA were subsequently analysed by real-time RT-PCR. Significant reduction in endogenous Tb 4 expression in these cells was indeed observed after they were infected by Ad-Tb 4 AS for 24 and 48 h (Figure 6a ). Interestingly, a dramatic decrease in ILK levels was found in Tb3 and Tb4 cells infected with Ad-Tb 4 AS (Figure 6b ). However, no restoration of E-cadherin levels in Tb3 and Tb4 cells could be found 3 days postinfection (data not shown).
Expression levels of ILK and E-cadherin correlate, respectively, with those of Tb 4 in human colorectal carcinoma As ILK expression was found to be upregulated by Tb 4 in cultured colon cancer cells (Figure 4a ), we asked whether such a causal relationship also existed in human (Table 1) and 16 (80%) of the Tb 4 -positive cases exhibited strong ILK staining (Figure 7 ), whereas 18 (90%) of the Tb 4 -positive cases exhibited negative E-cadherin staining. By contrast, none of the Tb 4 -negative patients were stained positively by anti-ILK antibody and six (66.7%) of the Tb 4 -negative patients were exhibited strong E-cadherin staining. After statistical analysis of these data, a strong positive correlation between Tb 4 and ILK expression as well as a strong negative correlation between Tb 4 and E-cadherin in CRC patients' tumor tissues was unequivocally established (Po0.005, Table 1 ).
Discussion
The loss of E-cadherin, a pivotal event for EMT, has been found to be associated with the malignant progression of more than 15 different types of carcinomas including CRC (Potter et al., 1999) . This critical cell adhesion molecule, in addition, also functions as a sequestering protein of b-catenin, a key mediator in Wnt signaling (Kikuchi, 2000) . We have previously shown that disruption of the actin microfilaments in SW480 colon carcinoma cells by overexpressing a G-actin binding peptide, Tb 4 , results in a drastic increase in their growth and motility which is likely to be accounted by a deregulated cell-cell adhesion arisen from E-cadherin downregulation, plus an uncontrolled cell proliferation owing to an enhanced b-catenin signaling (Wang et al., 2003) .
In the present study, we established several new Tb 4 -overexpressing permanent clones (Tb3 and Tb4) from the same colon cancer line (Figure 1a) , which not only exhibited fibroblastic morphology but also scattered (Figure 1b) , suggesting an EMT in these cells. In accordance with our previous findings (Wang et al., 2003) , E-cadherin levels were drastically decreased in these newly established Tb 4 overexpressers (Figure 1c) , which is unlikely to be attributed to its cleavage by MMPs (Lochter et al., 1997; Ito et al., 1999; Zucker et al., 2000; Noe¨et al., 2001) or an endocytosis-coupled degradation (Tsukamoto and Nigam, 1999; Palacios et al., 2005) , as neither the MMP inhibitor, the proteasome inhibitor, nor the lysosomotropic agent could restore E-cadherin levels in Tb3 and Tb4 cells (Figure 2a) .
Although a transcriptional silencing seems to be the main reason for E-cadherin downregulation in Tb 4 overexpressers (Figure 2b ), ZEB1, instead of Snail or Slug, was postulated to be the responsible repressor (Figure 2b and c) . In the meantime, as ZEB1 transcription could be activated by Snail (Guaita et al., 2002) plus the stability and nuclear translocation of Snail could be negatively regulated by GSK-3b (Zhou et al., 2004) , increased ZEB1 expression in Tb 4 overexpressers might be a result of inactivation of the aforementioned kinase (Figure 3c ). Consequentially, because the transcript stability of ZEB1 is much higher than that of Snail (Guaita et al., 2002) , it is possible that E-cadherin downregulation in Tb3 and Tb4 cells was achieved initially by Snail but was maintained later on by the long-lived ZEB1. More work is required to test this hypothesis.
In agreement with our earlier findings (Wang et al., 2003) , a significant increase in total as well as cytosolic levels of b-catenin was also observed in Tb3 and Tb4 cells (Figures 1c and 3b) , which is likely to be accounted by its protein stabilization because no increase in its mRNA could be detected (Figure 3a) crucial for its degradation (Cohen and Frame, 2001; Liu et al., 2002; Polakis, 2002) were dramatically diminished ( Figure 3b ). (Polakis, 2002) , which might be attributed to a diminished activity in CK1, and/or an inefficient APC (adenomatous polyposis coli) complex formation (Morin et al., 1997; Willert et al., 1999; Ha et al., 2004) . Intriguingly, cytosolic increase of b-catenin did not result in its nuclear accumulation (data not shown), supporting the idea that stabilization of this anchoring molecule per se is insufficient for its nuclear translocation (Provost et al., 2003; Gottardi and Gumbiner, 2004) .
Although the aberrant Wnt signaling was considered to be the main reason for GSK-3b inactivation in colon cancer cells, diminished activity of this kinase in Tb 4 -overexpressing SW480 cells might also be accounted in part by ILK, as the protein level ( Figure 4a ) and activity (Figure 4c ) of this enzyme, as well as the phosphorylation of its substrates Akt ( Figure 4b ) were all increased. By contrast, no alteration in a-parvin, an ILK-stimulating protein (Attwell et al., 2003) , was found (Figure 4a ), implying that activation of this kinase in Tb 4 overexpressers is independent of its complexing with aparvin. Moreover, the involvement of either PI3K (Figure 4c and d) or MEK (data not shown) signaling in upregulating ILK in these cells was also excluded, so were the transcriptional (Figure 5a ) and translational activation (data not shown). However, a stability increase in ILK resulted from a more efficient complex formation between this kinase and PINCH promoted by Tb 4 (Figure 5c ) might be the main reason for its upregulation in these cells and this assumption was supported by our finding that ILK levels were dramatically reduced after their Tb 4 expression was knocked down by Ad-Tb 4 AS infection (Figure 6b ). Most interestingly, an in situ Tb 4 -mediated ILK upregulation and Ecadherin downregulation was demonstrated for the first time by our immunohistochemical (IHC) analyses ( Figure 7 and Table 1 ). Taken together, we postulated that ILK is the most critical mediator for Tb 4 -induced EMT in colon cancer cells which might not only disrupt the cell-cell adhesions by downregulating E-cadherin expression, but also trigger a reorganization of the actin cytoskeleton by interacting with Rac and Cdc42 (Filipenko et al., 2005) and/or via recruiting the Arp2/ 3 complex through Wiskott-Aldrich syndrome protein activation (Brakebusch and Fa¨ssler, 2003) . Experiments dissecting the role of various Rho family members in EMT triggered by Tb 4 overexpression are currently undergone in our laboratory. [g-32 P]ATP was purchased from Perkin-Elmer, Life and Analytical Sciences (Boston, MA, USA). Galardin (GM6001), MG132 and myelin basic protein were purchased from Sigma (St Louis, MO, USA). All other chemicals were of analytical grade and were purchased from Sigma, unless otherwise specified.
Materials and methods
Reagents
Cell culture and transfection Stable clones carrying either the transfected mouse Tb 4 cDNA (Tb3 and Tb4) or the pBKCMV vector (Stratagene, La Jolla, CA, USA) (BK) were established from a human colon carcinoma cell line SW480 (American Type Culture Collection, Manassas, VA, USA, ATCC CCL-228) as described previously (Wang et al., 2003) .
Western blotting
For whole-cell lysate preparation, cells were washed with phosphate-buffered saline (PBS) and then scraped into PBS. After collection by centrifugation, cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholic acid and 1% Nonidet P-40, pH 8.0). Both PBS and RIPA buffer were supplemented with proteinase inhibitor cocktail (Calbiochem, San Diego, CA, USA). After centrifugation (10 000 g, 10 min), appropriate amounts of protein from the supernatant (total lysate) were separated on a 10% SDSpolyacrylamide gel and processed for immunoblotting with the appropriate antibodies and developed using enhanced chemiluminescence (Perkin-Elmer, Boston, MA, USA). For preparing cytosolic and nuclear extracts, ProteoExtract Subcellular Proteome Extraction Kit (Calbiochem, San Diego, CA, USA) was used according to the manufacture's protocol.
ILK kinase activity assay Cells were lysed in RIPA buffer supplemented with 5 mM NaF, 1 mM Na 3 VO 4 and proteinase inhibitor cocktail. Hundred micrograms of protein samples and anti-ILK antibody (3 mg/ sample) were precleared with Protein A/G PLUS-Agarose at 41C for 2 h, respectively. Following centrifugation (500 g, 30 s), lysates were incubated with the anti-ILK antibody at 41C for 10 h. After being washed three times with the kinase reaction buffer (50 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, 10 mM MnCl 2 , 10mM MgCl 2 , 2 mM NaF, 1 mM Na 3 VO 4 , pH 7.0), the immunoprecipitated ILK was incubated with 10 mg of myelin basic protein and 10 mCi of [g-32 P]ATP in a total volume of 50 ml at 301C for 20 min. The reaction was stopped by the addition of an equal volume of 2 Â SDSpolyacrylamide gel electrophoresis sample buffer and the products were detected by autoradiography after being separated on a 12% SDS-polyacrylamide gel.
RT-PCR analysis Cells were lysed in 1 ml of Ultraspec-II RNA kit (Biotecx Lab. Inc., Houston, TX, USA) and total RNA was harvested according to the manufacture's protocol. Five micrograms of total RNA were subjected to RT by RevertAid M-MuLV reverse transcriptase (Fermentas Inc., Hanover, MD, USA) using oligo(dT) as primer. Following RT, 1/10 to 1/5 of the reaction products was used for PCR amplification by Taq2000 DNA polymerase (Stratagene, La Jolla, CA, USA) with the following primer sets: for mouse- 
Quantitative real-time PCR assay
To analyse the expression of human Tb 4 gene before and after virus infection, RT using total 5 mg RNAs was performed as described above. Quantitative real-time PCR was then carried out in a Mini Opticon real-time PCR System (Bio-Rad, Hercules, CA, USA), using cDNA template (1/20 of the RT reaction products), 100 ng of forward (5 0 -ATGTCTGACA AACCCGATATG-3 0 ) and reverse (5 0 -AGATTTCACTG TCGTCCCACC-3 0 ) primers and 10 ml of iQ SYBR green supermix (Bio-Rad, Hercules, CA, USA) in a total volume of 20 ml with the following program: initial denaturation at 951C for 5 min, followed by 30 cycles of: 951C 20 s, 551C 20 s, 721C 30 s and finally 721C for 2 min. Each experiment was repeated three times, and the amount of Tb 4 mRNA was normalized with that of the GAPDH.
Analysis of ZEB1 promoter activity
The human ZEB1 promoter was obtained by PCR amplification of human genomic DNA using forward primer: 5 0 -TCC AGACCGCGATCCCTTTCCTT-3 0 (nucleotide (nt) 73261, AL117340) and reverse primer: 5 0 -CCTCTCGCTTGTGT CTAAATGC-3 0 (nt 73832), containing BglII and EcoRI sites at the 5 0 ends, respectively. The PCR fragment was cloned into the BglII and EcoRI sites of pSEAP2 (Clontech, Mountain View, CA, USA) to obtain pZEB1-SEAP. SW480, BK, Tb3 and Tb4 cells were co-transfected with 0.8 mg pZEB1-SEAP and 0.08 mg pGL3-luciferase (Promega, Madison, WI, USA) by Lipofectamine (Invitrogen, Grand Island, NY, USA). Forty-eight hours after transfection, culture media were collected for secretory alkaline phosphatase (SEAP) assays as described (Yang et al., 2005) and total lysates were prepared for luciferase assays using the dual-luciferase reporter assay system (Promega, Madison, WI, USA) to normalize the transfection efficiency.
Downregulation of Tb 4 expression by adenovirus infection
The pShuttle-CMV vector (AdEasy XL Adenoviral vector system, Stratagene) was ligated with a Tb 4 gene (in an antisense orientation) and a GFP DNA fragment, respectively. The resulting plasmids, pShuttle-CMV-antisense-Tb 4 and pShuttle-CMV-GFP, were then linearized by PmeI, and transformed into BJ5183 cells. Successful recombination was confirmed by the appearance of a 3-or 4.5-kb DNA fragment after PacI digestion. The resulting recombinant adenoviral genomes after being linearized by PacI were transfected into Ad293 cells by lipofectamine. Forty-eight hours later, cells were harvested and disrupted by repeated freezing-thawing, and the viruses in cytosol were collected and further amplified in Ad293 cells. To prepare large amount of pure viruses, cesium chloride (0.55 g/ml) was added into the cytosol pooled from 10 150-mm dishes of infected cells and this solution was then subjected to ultracentrifugation at 130 000 g for 18 h. Virus particles were collected, mixed with an equal volume of stock buffer (20 mM Tris-HCl, 4 mM MgCl 2 , 8% sucrose) and stored at À701C until use. The infection was carried out by incubating cells with the viruses (multiplicity of infection (MOI) ¼ 800 to 1000) in a serum-free condition for 1 h. A complete medium was then used to replace the virus-containing one and the infected cells were cultured under a standard condition until being processed for further analysis.
Immunohistochemical staining of Tb 4 , ILK and E-cadherin Between 2004 and 2005, a total of 29 patients with histologically confirmed metastatic CRC treated at Taipei Veterans General Hospital were enrolled. They all received 5-FU-based chemotherapy. IHC analysis of the tissue samples was performed. Briefly, formalin-fixed, paraffin-embedded tissue samples from these patients were sectioned, placed on slides and de-paraffinized. For Tb 4 staining, a polyclonal antiTb 4 antibody and a biotin-conjugated anti-rabbit IgG antibody were used as primary and secondary antibodies, respectively, followed by a sensitive peroxidase-conjugated streptavidin system (BioGenex, San Ramon, CA, USA). A similar protocol was applied for both ILK and E-cadherin staining.
